Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
4570 On Other Exchanges
4570 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

immuno-biological laboratori (4570) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IMMUNO-BIOLOGICAL LABORATORI (4570)

Related News

No related news articles were found.

immuno-biological laboratori (4570) Related Businessweek News

No Related Businessweek News Found

immuno-biological laboratori (4570) Details

Immuno-Biological Laboratories Co., Ltd. provides various medicines and in-vitro diagnostic products used to promote the fight against diseases in Japan. It develops antibodies against proteins related to intractable diseases, such as cancers, autoimmune diseases, and disorders of the brain and nervous system; and manufactures diagnostic tests that make the use of antibodies. The company also offers various reagents, such as antibodies for alzheimer's disease, osteopontin, immunoglobulins, immunohistochemistry, cancer research, cytokines, and other research; EIA kits that assay target proteins by using the antigen antibody reaction; and proteins. In addition, it develops various transgenic animal models; and provides antibody drug candidates, as well as offers custom services on crossbreeding with other transgenic mice and the function analysis of those animals. Further, the company manufactures AsthNon 3000, a soft water drink that is used as a sports supplement to improve moving ability. It markets its products through a network of distributors and dealers in the United States and Europe. Immuno-Biological Laboratories Co., Ltd. was founded in 1982 and is headquartered in Fujioka, Japan.

55 Employees
Last Reported Date: 06/29/15
Founded in 1982

immuno-biological laboratori (4570) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

immuno-biological laboratori (4570) Key Developments

Immuno-Biological Laboratories Co., Ltd. to Report Q1, 2016 Results on Aug 04, 2015

Immuno-Biological Laboratories Co., Ltd. announced that they will report Q1, 2016 results on Aug 04, 2015

Immuno-Biological Laboratories Co., Ltd., Annual General Meeting, Jun 26, 2015

Immuno-Biological Laboratories Co., Ltd., Annual General Meeting, Jun 26, 2015.

Immuno-Biological Laboratories Co., Ltd., 2015 Earnings Call, May 29, 2015

Immuno-Biological Laboratories Co., Ltd., 2015 Earnings Call, May 29, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4570:JP ¥1,155.00 JPY -34.00

4570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4570.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4570 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.9x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNO-BIOLOGICAL LABORATORI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at